A citation-based method for searching scientific literature

Sharon E Plon, H Paul Cooper, Bethany Parks, Shweta U Dhar, P Adam Kelly, Armin D Weinberg, Stephanie Staggs, Tao Wang, Susan Hilsenbeck. Genet Med 2011
Times Cited: 77







List of co-cited articles
356 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prospective functional voice assessment in patients undergoing thyroid surgery.
Alexander Stojadinovic, Ashok R Shaha, Robert F Orlikoff, Aviram Nissan, Mary-Frances Kornak, Bhuvanesh Singh, Jay O Boyle, Jatin P Shah, Murray F Brennan, Dennis H Kraus. Ann Surg 2002
172
1

Staging systems for papillary thyroid carcinoma: a review and comparison.
Brian Hung-Hin Lang, Chung-Yau Lo, Wai-Fan Chan, King-Yin Lam, Koon-Yat Wan. Ann Surg 2007
164
1

The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size.
Kelly L McCoy, Noel Jabbour, Jennifer B Ogilvie, N Paul Ohori, Sally E Carty, John H Yim. Surgery 2007
149
1

The impact of goitre and its treatment on the trachea, airflow, oesophagus and swallowing function. A systematic review.
Jesper Roed Sørensen, Laszlo Hegedüs, Søren Kruse-Andersen, Christian Godballe, Steen Joop Bonnema. Best Pract Res Clin Endocrinol Metab 2014
18
5

Use of the Nerve Integrity Monitor during Thyroid Surgery Aids Identification of the External Branch of the Superior Laryngeal Nerve.
Anthony R Glover, Olov Norlén, Justin S Gundara, Michael Morris, Stan B Sidhu. Ann Surg Oncol 2015
20
5

Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis.
Xiaoyun Liu, Marco Medici, Norra Kwong, Trevor E Angell, Ellen Marqusee, Matthew I Kim, P Reed Larsen, Nancy L Cho, Matthew A Nehs, Daniel T Ruan,[...]. Thyroid 2016
36
2

Assessment of Vocal Fold Function Using Transcutaneous Laryngeal Ultrasonography and Flexible Laryngoscopy.
Emad Kandil, Ahmed Deniwar, Salem I Noureldine, AbdulRahman Y Hammad, Hossam Mohamed, Zaid Al-Qurayshi, Ralph P Tufano. JAMA Otolaryngol Head Neck Surg 2016
22
4



Role of thyroid Doppler in differential diagnosis of thyrotoxicosis.
K V S Hari Kumar, Vamsikrishna Pasupuleti, Muthukrishnan Jayaraman, Verma Abhyuday, Ramasubba Rayudu B, Kirtikumar D Modi. Endocr Pract 2009
29
3

Age and comorbidity as risk factors for vocal cord paralysis associated with tracheal intubation.
M Kikura, K Suzuki, T Itagaki, T Takada, S Sato. Br J Anaesth 2007
59
1

A national analysis of trends, outcomes and volume-outcome relationships in thyroid surgery.
S A R Nouraei, J S Virk, S E Middleton, P Aylin, A Mace, F Vaz, H Kaddour, A Darzi, N S Tolley. Clin Otolaryngol 2017
26
3


Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls.
Giuseppe Costante, Cosimo Durante, Zélia Francis, Martin Schlumberger, Sebastiano Filetti. Nat Clin Pract Endocrinol Metab 2009
76
1

Ligasure versus Ultracision in thyroid surgery: a prospective randomized study.
Paola Vincenza Sartori, Sergio De Fina, Giovanni Colombo, Francesco Pugliese, Fabrizio Romano, Giovanni Cesana, Franco Uggeri. Langenbecks Arch Surg 2008
68
1

A randomized, prospective, parallel group study comparing the Harmonic Scalpel to electrocautery in thyroidectomy.
Carlos Cordón, Rafael Fajardo, Jaqueline Ramírez, Miguel F Herrera. Surgery 2005
93
1

Management of Graves Disease: A Review.
Henry B Burch, David S Cooper. JAMA 2015
115
1


Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma.
Richard J Robbins, Shefali Srivastava, Ashok Shaha, Ronald Ghossein, Steven M Larson, Martin Fleisher, R Michael Tuttle. J Clin Endocrinol Metab 2004
43
2

Systematic review and meta-analysis on intra-operative neuro-monitoring in high-risk thyroidectomy.
Kai Pun Wong, Ka Lun Mak, Carlos King Ho Wong, Brian Hung Hin Lang. Int J Surg 2017
40
2


A 2015 Italian Survey of Clinical Practice Patterns in the Management of Graves' Disease: Comparison with European and North American Surveys.
Roberto Negro, Roberto Attanasio, Franco Grimaldi, Rinaldo Guglielmi, Enrico Papini. Eur Thyroid J 2016
9
11

Delphian node metastasis in head and neck cancers--oracle or myth?
N Gopalakrishna Iyer, Ashok R Shaha, Alfio Ferlito, K Thomas Robbins, Jesus E Medina, Carl E Silver, Alessandra Rinaldo, Robert P Takes, Carlos Suárez, Juan P Rodrigo,[...]. J Surg Oncol 2010
18
5

Intrathyroid adenomas in primary hyperparathyroidism: are they frequent enough to guide surgical strategy?
Uta Herden, Christian A Seiler, Daniel Candinas, Stefan W Schmid. Surg Innov 2011
3
33

Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
Linwah Yip, Marina N Nikiforova, Jenny Y Yoo, Kelly L McCoy, Michael T Stang, Michaele J Armstrong, Kristina J Nicholson, N Paul Ohori, Christopher Coyne, Steven P Hodak,[...]. Ann Surg 2015
55
1

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
Martin P Nilsson, Therese Törngren, Karin Henriksson, Ulf Kristoffersson, Anders Kvist, Barbro Silfverberg, Åke Borg, Niklas Loman. Breast Cancer Res Treat 2018
8
12



Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.
Angela R Bradbury, Linda Patrick-Miller, Jessica Long, Jacquelyn Powers, Jill Stopfer, Andrea Forman, Christina Rybak, Kristin Mattie, Amanda Brandt, Rachelle Chambers,[...]. Genet Med 2015
50
2

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Rossella Graffeo, Luca Livraghi, Olivia Pagani, Aron Goldhirsch, Ann H Partridge, Judy E Garber. Breast Cancer Res Treat 2016
35
2

BRCA1/2 genetic testing uptake and psychosocial outcomes in men.
Kristi D Graves, Rhoda Gatammah, Beth N Peshkin, Ayelet Krieger, Christy Gell, Heiddis B Valdimarsdottir, Marc D Schwartz. Fam Cancer 2011
16
6

Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.
Marc D Schwartz, Beth N Peshkin, Claudine Isaacs, Shawna Willey, Heiddis B Valdimarsdottir, Rachel Nusbaum, Gillian Hooker, Suzanne O'Neill, Lina Jandorf, Scott P Kelly,[...]. Breast Cancer Res Treat 2018
8
12

Development and testing of the KnowGene scale to assess general cancer genetic knowledge related to multigene panel testing.
Meghan Underhill-Blazey, Jill Stopfer, Anu Chittenden, Manan M Nayak, Kristina Lansang, Ruth Lederman, Judy Garber, Daniel A Gundersen. Patient Educ Couns 2019
6
16

Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain.
I Esteban, M Vilaró, E Adrover, A Angulo, E Carrasco, N Gadea, A Sánchez, T Ocaña, G Llort, R Jover,[...]. Psychooncology 2018
16
6

Communication about genetic testing with breast and ovarian cancer patients: a scoping review.
Chris Jacobs, Christine Patch, Susan Michie. Eur J Hum Genet 2019
17
5

Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial.
Veronica F Quinn, Bettina Meiser, Judy Kirk, Kathy M Tucker, Kaaren J Watts, Belinda Rahman, Michelle Peate, Christobel Saunders, Elizabeth Geelhoed, Margaret Gleeson,[...]. Genet Med 2017
18
5


Use and Patient-Reported Outcomes of Clinical Multigene Panel Testing for Cancer Susceptibility in the Multicenter Communication of Genetic Test Results by Telephone Study.
Michael J Hall, Linda J Patrick-Miller, Brian L Egleston, Susan M Domchek, Mary B Daly, Pamela Ganschow, Generosa Grana, Olufunmilayo I Olopade, Dominique Fetzer, Amanda Brandt,[...]. JCO Precis Oncol 2018
7
14

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.
Nicoletta Colombo, Gloria Huang, Giovanni Scambia, Eva Chalas, Sandro Pignata, James Fiorica, Linda Van Le, Sharad Ghamande, Santiago González-Santiago, Isabel Bover,[...]. J Clin Oncol 2018
42
2

Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing.
Angela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, Laura DiGiovanni, Jamie Brower, Diana Harris, Evelyn M Stevens, Kara N Maxwell, Abha Kulkarni, Tyler Chavez,[...]. Genet Med 2016
39
2

High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.
Martin P Nilsson, Erik D Nilsson, Åke Borg, Yvonne Brandberg, Barbro Silfverberg, Niklas Loman. Breast Cancer Res Treat 2019
6
16

Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis.
Mingming Liang, Yun Zhang, Chenyu Sun, Feras Kamel Rizeq, Min Min, Tingting Shi, Yehuan Sun. Mol Diagn Ther 2018
8
12

Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?
Cezary Cybulski, Dominika Wokołorczyk, Józef Kładny, Grzegorz Kurzawski, Joanna Suchy, Ewa Grabowska, Jacek Gronwald, Tomasz Huzarski, Tomasz Byrski, Bohdan Górski,[...]. Eur J Hum Genet 2007
46
2

Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group.
Amy Taylor, Angela F Brady, Ian M Frayling, Helen Hanson, Marc Tischkowitz, Clare Turnbull, Lucy Side. J Med Genet 2018
41
2

CHEK2 I157T associates with familial and sporadic colorectal cancer.
O Kilpivaara, P Alhopuro, P Vahteristo, L A Aaltonen, H Nevanlinna. J Med Genet 2006
54
1

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Melissa C Southey, David E Goldgar, Robert Winqvist, Katri Pylkäs, Fergus Couch, Marc Tischkowitz, William D Foulkes, Joe Dennis, Kyriaki Michailidou, Elizabeth J van Rensburg,[...]. J Med Genet 2016
98
1

Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks.
Brennan Decker, Jamie Allen, Craig Luccarini, Karen A Pooley, Mitul Shah, Manjeet K Bolla, Qin Wang, Shahana Ahmed, Caroline Baynes, Don M Conroy,[...]. J Med Genet 2017
33
3

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy.
M Kriege, A Hollestelle, A Jager, P E A Huijts, E M Berns, A M Sieuwerts, M E Meijer-van Gelder, J M Collée, P Devilee, M J Hooning,[...]. Br J Cancer 2014
34
2

Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion.
Ahmad N Abou Tayoun, Tina Pesaran, Marina T DiStefano, Andrea Oza, Heidi L Rehm, Leslie G Biesecker, Steven M Harrison. Hum Mutat 2018
117
1

Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors.
Saud H AlDubayan, Louise C Pyle, Marija Gamulin, Tomislav Kulis, Nathanael D Moore, Amaro Taylor-Weiner, Anis A Hamid, Brendan Reardon, Bradley Wubbenhorst, Rama Godse,[...]. JAMA Oncol 2019
17
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.